Abstract
The authors investigated the relationship between statin use and the risk of stroke in the Heart and Estrogen-Progestin Replacement Study (HERS). Despite large reductions in relative risk point estimates, statin use was not associated with differences in the risks of all fatal stroke (relative hazard [RH] 0.52, 95% CI 0.23 to 1.18, p = 0.12), fatal ischemic stroke (RH 0.51, 95% CI 0.18 to 1.45, p = 0.21), fatal hemorrhagic stroke (RH 0.18, 95% CI 0.02 to 1.46, p = 0.11), or TIA (RH 1.32, 95% CI 0.84 to 2.09, p = 0.23).
| Original language | English |
|---|---|
| Pages (from-to) | 968-970 |
| Number of pages | 3 |
| Journal | Neurology |
| Volume | 62 |
| Issue number | 6 |
| DOIs | |
| State | Published - Mar 23 2004 |
ASJC Scopus subject areas
- Clinical Neurology
Fingerprint
Dive into the research topics of 'Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver